Adenoid cystic carcinoma evaluation and management: progress with optimism!

Area of Science:

• Oncology
• Pathology
• Genetics

Background:

• Adenoid cystic carcinoma (ACC) presents significant diagnostic and treatment challenges.
• The standard treatment for ACC, surgery and postoperative radiotherapy, has been unchanged for three decades.
• Previous reviews on ACC were published in 2004, necessitating an update on recent advancements.

Purpose of the Study:

• To review and update recent findings in adenoid cystic carcinoma (ACC) diagnosis and treatment since 2004.
• To explore novel therapeutic strategies emerging from molecular and genetic research in ACC.
• To assess the impact of new research on improving patient outcomes and long-term survival in ACC.

Main Methods:

• Review of recent literature on adenoid cystic carcinoma (ACC).
• Analysis of histological diagnosis and staging methods.
• Examination of molecular and genetic findings in ACC.

Main Results:

• Accurate histological diagnosis and staging are crucial for ACC treatment planning.
• Long-term prognosis in ACC is influenced by the presence of solid tumor components.
• Current treatment of surgery and radiotherapy has not significantly improved long-term outcomes, with loco-regional failure and distant metastases being primary causes of death.
• Molecular and genetic research is generating optimism for novel, complementary treatments for ACC.

Conclusions:

• Histological grading by optical methods has not improved ACC treatment selection.
• Emerging molecular and genetic research offers potential for reclassifying ACC.
• New findings may lead to tailored treatments, improving tumor-free survival and prolonging patient life in ACC.
• Further research into molecular and genetic factors is essential for advancing ACC treatment paradigms.